The best stocks to buy since 1993

Latest issue now available

DiscoverIE - 15 deals in live negotiation

January 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • DSCV
  • Price:
  • 740p
Against tough comps of 20% growth last year, the latest H1 results for DiscoverIE, which makes components for electronic applications, were decent with the shares jumping £1 on the day. Sales might have looked flat at £222m (+4% on constant currency) but adjusted operating profit was +12% to £28.6m driven by efficiency gains (eg. site consolidation/production cost optimisation) and a better mix (inclusion of the very high margin acquired businesses e.g Beacon), with the operating margin lifting by 1.4% to 12.9%. Eps grew 8% to 19.2p. DiscoverIE operates through its two divisions with 76% of sales going into four resilient target markets of renewable energy, medical, electrification of transportation and industrial automatio ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X



To access our archive of articles and to receive current issues you need to subscribe